Font, A <br/><br/>
Sequential mitoxantrone/prednisone followed by docetaxel/estramustine in patients with hormone refractory metastatic prostate cancer: results of a phase II study.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Mar 2005 
 - 419-24 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdi096  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Docetaxel<br/>Drug Administration Schedule<br/>Drug Resistance, Neoplasm<br/>Estramustine--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Mitoxantrone--administration & dosage<br/>Prednisone--administration & dosage<br/>Prostate-Specific Antigen--blood<br/>Prostatic Neoplasms--drug therapy<br/>Survival Analysis<br/>Taxoids--administration & dosage